Gts Securities »

Liminatus Pharma shares owned by Gts Securities

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.4k 30k 0.15

More positions owned by Gts Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Meta Platforms Cl A (META)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Select Sector Spdr Tr Financial (XLF)

View all positions for Gts Securities

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma